Angene Chemical
Draw
|
Currency :
Home Products

AG002ZJN

302962-49-8 | N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide

Chemical structure of N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide, CAS 302962-49-8
AG002ZJN
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 302962-49-8
Catalog Number AG002ZJN(AGN-PC-0R5NJ2)
Chemical Name N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide
EC Number 801-607-0
IUPAC Name N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
InChI InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)
InChI Key ZBNZXTGUTAYRHI-UHFFFAOYSA-N
MDL Number MFCD08704581
Molecular Formula C22H26ClN7O2S
Molecular Weight 488.0055
SMILES O=C(Nc1c(cccc1Cl)C)c4cnc(Nc2nc(nc(c2)N3CCN(CCO)CC3)C)s4
UNII X78UG0A0RN
Synonyms
(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide, 354825, BMS, BMS 354825, BMS-354825, BMS354825, dasatinib, N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide, Sprycel, Dasatinib, 302962-49-8, Sprycel, BMS-354825, BMS 354825, BMS354825, dasatinibum, Dasatinib (anhydrous), Dasatinib (BMS-354825), N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE, N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide, anh. dasatinib, Dasatinib [USAN], BMS Dasatinib, UNII-X78UG0A0RN, anhydrous dasatinib, dasatinib (anh.), N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide, CHEMBL1421, X78UG0A0RN, CHEBI:49375, Dasatinib D8, NSC732517, NSC-732517, NCGC00181129-01, Dasatinib anhydrous, DSSTox_CID_20979, DSSTox_RID_79608, DSSTox_GSID_40979, 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-, Q-101345, 2-{6-[4-(2-Hydroxy-ethyl)-piperazin-1-yl]-2-methyl-pyrimidin-4-ylamino}-thiazole-5-carboxylic acid (2-chloro-6-methyl-phenyl)-amide, 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide, SMR002529551, CAS-302962-49-8, 302962-49-8 pound not863127-77-9, Dasatinib [USAN:INN], BMS-354825-03, Dasatinib, BMS 354825, Dasatinib;, 1N1, n-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide, Kinome_3650, Dasatinib (JAN/INN), AC1MI3ET, Sprycel (Bristol Meyers), AC1Q2P0C, SCHEMBL8226, Dasatinib BMS-354825, Dasatinib,BMS-354825, MLS003915609, MLS004774145, MLS006010904, BMS 354825|||Sprycel, Dasatinib - BMS-354825, GTPL5678, DTXSID4040979, BDBM13216, cid_3062316, CTK8B4120, EX-A401, QCR-106, SYN1036, ZBNZXTGUTAYRHI-UHFFFAOYSA-N, 5-Thiazolecarboxamide, monohydrate, BCPP000263, HMS2043N05, HMS3244A05, HMS3244A06, HMS3244B05, HMS3265C19, HMS3265C20, HMS3265D19, HMS3265D20, HMS3654K05, Pharmakon1600-01502275, AOB87355, BCP01797, ZINC3986735, Tox21_112736, 2359AH, ANW-43935, CD0138, FC0026, MFCD11046566, NSC759877, s1021, AKOS015902363, Tox21_112736_1, AN-5289, API0002220, BCP9000589, BMS 345825, CS-0100, DB01254, GS-6548, NSC-759877, RTR-013021, RTR-021205, SB17284, TRA0075817, KS-0000027F, NCGC00181129-02, NCGC00181129-03, NCGC00181129-05, NCGC00181129-06, NCGC00181129-12, 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide, AC-22749, AK-47532, BCB03_000715, BMS 35482513, BR-47532, EN002710, HY-10181, OR302638, SC-22079, AB0066750, AX8035158, LS-186641, LS-187028, LS-187773, ST2419212, TR-013021, AM20080877, FT-0084503, FT-0650671, SW208076-5, EC-000.2122, A-2429, D-3307, D03658, 49310-EP2270008A1, 49310-EP2292617A1, 49310-EP2311840A1, AB01273956-01, AB01273956-02, AB01273956_03, SR-00000000554, I14-1972, SR-00000000554-5, BRD-K49328571-001-05-1, BRD-K49328571-001-07-7, BMS-354825;BMS354825;BMS 354825, Z2786158251, N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thia, N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide, Spyrcel, Dasatinib hydrate, Dasatinib (USAN), SPRYCEL (TN), C22H26ClN7O2S, D0E6XR, cc-352, Tyrosine Kinase Inhibitor - Ns, C22-H26-Cl-N7-O2-S, ACN-029236, CID3062316, CS-O-01350, 354825, BMS, A3017, A10290, BMS-354825, Sprycel, BMS354825, Dasatinib, C488369, D000069439, (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide, 10025-91-9, 1132093-70-9, 183319-69-9, 5-tiazolcarboxamida, n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-, 863127-77-9, N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate, na,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited